PRELUDE CAPITAL MANAGEMENT, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1387508 NEW YORK, NY

Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$591,776

+$343,280 QoQ

Shares Held

4,684

+162.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#1,305

of 2,265 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Derivatives in GILD

reported options exposure · as of Dec 31, 2020

CallValue

$1,322,502

CallShares

22,700

PutValue

$0

PutShares

0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $9,540,290 across 6 Drug Manufacturers - General names. GILD ranks #4 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,543	$3,050,150
2	PFE	Pfizer Inc	117,746	$2,835,323
3	OGN	Organon & Co.	183,473	$2,484,224
4	GILD	Gilead Sciences, Inc. This page	4,684	$591,776
5	JNJ	Johnson & Johnson	1,370	$347,938
6	NVO	Novo Nordisk A S	4,816	$230,879

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$591,776	4,684	+162.7%	Shares	Other	2026-08-14
2026-03-31	$248,496	1,783	-80.8%	Shares	Other	2026-05-15
2025-06-30	$1,027,099	9,264	+276.4%	Shares	Other	2025-08-14
2025-03-31	$275,755	2,461	-76.7%	Shares	Other	2025-05-15
2024-12-31	$975,427	10,560	-27.1%	Shares	Other	2025-02-14
2024-09-30	$1,214,003	14,480	+163.8%	Shares	Other	2024-11-14
2022-03-31	$326,261	5,488	-69.4%	Shares	Other	2022-05-16
2021-12-31	$1,303,712	17,955	-21.7%	Shares	Other	2022-02-14
2021-03-31	$1,481,384	22,921	+184.9%	Shares	Other	2021-05-17
2020-12-31	$1,322,502	22,700	+345.1%	Call	Other	2021-02-16
2020-12-31	$468,759	8,046	+15.9%	Shares	Other	2021-02-16
2020-09-30	$438,538	6,940	-16.0%	Shares	Other	2020-11-16
2020-06-30	$392,394	5,100	+1175.0%	Call	Other	2020-08-14
2020-06-30	$635,293	8,257	-65.6%	Shares	Other	2020-08-14
2020-03-31	$1,796,931	24,036	—	Shares	Other	2020-05-15
2020-03-31	$29,904	400	—	Call	Other	2020-05-15
No filing history on record for this holder in this stock.

PRELUDE CAPITAL MANAGEMENT, LLC

Position in GILD

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

Position in Drug Manufacturers - General

All Filings in GILD